Drug intelligence / Profile preview

measles + inactivated polio vaccine

Development stage
Unknown
Lead developer
Sanofi
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

A combination vaccine containing both measles virus antigen and inactivated poliovirus antigens. This product is designed to provide immunization against both measles and poliomyelitis (polio) in a single injection. The measles component is typically a live attenuated virus, while the polio component consists of trivalent (types 1, 2, and 3) inactivated polioviruses. Such combination vaccines are intended to simplify immunization schedules by reducing the number of injections required for protection against these diseases. While combination vaccines with DTP, Hib, hepatitis B, and IPV are widely used (e.g., Pentacel, Pediarix), there is no evidence from current sources that a licensed commercial vaccine exists combining only measles and inactivated polio antigens without additional components[1][7]. However, co-administration of separate measles-containing vaccines (such as MMR or monovalent measles) with IPV is common practice[10].

02

Targets

MV (Measles virus)

Beyond the preview

Go deeper on measles + inactivated polio vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on measles + inactivated polio vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call